focus -WSS

focus

author：knowledge 2025-09-27 22:59:53 - browse：748

Moderna chairman Noubar Afeyan exuded star power earlier this month as he commanded the spotlight at BIO 2023, the industry’s largest convention.

Basking in the accolades heaped on Moderna’s celebrated Covid-19 vaccine, Afeyan regaled the Boston audience with the company’s origin story and greeted fans who lined up to snap selfies with him. Stuart Cable, a partner in the law firm Goodwin who’s represented Moderna and joined Afeyan on stage, called Moderna “arguably the most successful story in the history of biotechnology.”

But the Cambridge, Mass.-based company can’t afford to rest on its laurels. Two and a half years after its vaccine liberated tens of millions from pandemic lockdowns — ringing up more than $36 billion in sales so far — Moderna faces a changing business and regulatory environment. Demand for Covid shots is waning, a backlash over drug prices is gaining traction, and questions about its next act loom.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Medicare must police algorithms in Medicare Advantage, Dems say

focus

WSS

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Lung cancer screening guidelines updated for cigarette smokers

Coercive sterilizations revealed by STAT prompt outrage

The system is set up to fail children with medical complexity

Travis Kelce and the trap of celebrity vaccine endorsements

Bill would allow buprenorphine prescription for addiction via telehealth

knowledge

focus

leisure time

Virginia high school admissions case could be legal follow

Prime Medicine says its gene editing passes test in monkeys

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Travis Kelce and the trap of celebrity vaccine endorsements

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: The Sarepta saga, decoding biotech hype

What does generative AI mean for health care? We asked experts

Lung cancer screening guidelines updated for cigarette smokers

Apple is now the first public company to be valued at $3 trillion

Infant mortality in U.S. rose last year for first time in decades: CDC

Wikipedia

The system is set up to fail children with medical complexity

Cigna wins case to block Amy Bricker's move to CVS

Explaining an after

The system is set up to fail children with medical complexity

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Sarepta Duchenne therapy fails to meet primary endpoint in trial

explore

leisure time

focus

entertainment